ATE239502T1 - Impfung mit peptiden von mhc klasse ii molekülen zur behandlung von autoimmunkrankheiten - Google Patents

Impfung mit peptiden von mhc klasse ii molekülen zur behandlung von autoimmunkrankheiten

Info

Publication number
ATE239502T1
ATE239502T1 AT94904861T AT94904861T ATE239502T1 AT E239502 T1 ATE239502 T1 AT E239502T1 AT 94904861 T AT94904861 T AT 94904861T AT 94904861 T AT94904861 T AT 94904861T AT E239502 T1 ATE239502 T1 AT E239502T1
Authority
AT
Austria
Prior art keywords
peptides
treatment
mhc class
vaccination
molecules
Prior art date
Application number
AT94904861T
Other languages
English (en)
Inventor
Subramaniam Sriram
Bishwajit Nag
Somesh D Sharma
Original Assignee
Subramaniam Sriram
Bishwajit Nag
Somesh D Sharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Subramaniam Sriram, Bishwajit Nag, Somesh D Sharma filed Critical Subramaniam Sriram
Application granted granted Critical
Publication of ATE239502T1 publication Critical patent/ATE239502T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT94904861T 1992-12-17 1993-12-16 Impfung mit peptiden von mhc klasse ii molekülen zur behandlung von autoimmunkrankheiten ATE239502T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US99294292A 1992-12-17 1992-12-17
PCT/US1993/012351 WO1994013320A1 (en) 1992-12-17 1993-12-16 Vaccination with peptide of mhc class ii molecules for treatment of autoimmune disease

Publications (1)

Publication Number Publication Date
ATE239502T1 true ATE239502T1 (de) 2003-05-15

Family

ID=25538911

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94904861T ATE239502T1 (de) 1992-12-17 1993-12-16 Impfung mit peptiden von mhc klasse ii molekülen zur behandlung von autoimmunkrankheiten

Country Status (7)

Country Link
EP (1) EP0674526B1 (de)
JP (1) JPH08509204A (de)
AT (1) ATE239502T1 (de)
AU (1) AU5872594A (de)
CA (1) CA2152075C (de)
DE (1) DE69332956D1 (de)
WO (1) WO1994013320A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6045796A (en) * 1992-12-17 2000-04-04 Anergen, Inc. Vaccination with peptide of MHC class II molecules for treatment of autoimmune disease
CA2169762A1 (en) * 1994-06-16 1995-12-21 Carol Clayberger Immune modulation with class ii alpha-chain fragments
IT1274592B (it) * 1994-08-05 1997-07-18 Angela Turiano Composizione farmaceutica per la terapia tumorale contenente xenoantigeni
US20030118594A1 (en) * 1995-06-07 2003-06-26 Bishwajit Nag Stable formulations of mhc-peptide complexes
AU4454700A (en) * 1999-04-12 2000-11-14 Stanford University Interaction of mhc class ii proteins with members of the pcna family of proteins
EP1715343B1 (de) * 2005-04-20 2009-12-09 F. Hoffmann-La Roche Ag Verfahren zur Identifizierung von Epitopen in Zusammenhang mit Immunogenität bei Biopharmazeutika

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1327162C (en) * 1987-04-09 1994-02-22 Board Of Trustees Of The Leland Stanford Junior University (The) Method for prophylactically treating an individual for an autoimmune disease
WO1992016234A1 (en) * 1991-03-22 1992-10-01 The Trustees Of The University Of Pennsylvania Method of modulating mammalian t-cell response

Also Published As

Publication number Publication date
AU5872594A (en) 1994-07-04
EP0674526B1 (de) 2003-05-07
EP0674526A4 (de) 1997-01-15
JPH08509204A (ja) 1996-10-01
CA2152075A1 (en) 1994-06-23
CA2152075C (en) 2001-04-10
DE69332956D1 (de) 2003-06-12
EP0674526A1 (de) 1995-10-04
WO1994013320A1 (en) 1994-06-23

Similar Documents

Publication Publication Date Title
ATE352559T1 (de) Verfahren zur verminderung der immunogenität von proteinen
GEP20022695B (en) Moraxella Catarrhalis Outer Membrane Protein-106 Polypeptide, Gene Sequence and Uses Thereof
DE69718150T2 (de) Peptid-immunogene zur schutzimpfung gegen und behandlung von allergien
CA2290485A1 (en) Method for the production of non-immunogenic proteins
ATE415173T1 (de) Pan dr-bindeproteinen zur erhöhung der immunantwort
MX9703643A (es) Metodos para tratamiento de esclerosis multiple usando analogos de peptidos de proteina basica de mielina humana.
ATE198050T1 (de) Therapeutische anwendungen von bpi-protein- produkten zur behandlung von humaner meningococcämia
DE69726426D1 (de) Unterdrückung von immunantwort durch hemmung von cathepsin s
NL300830I2 (nl) Protein Q, een recombinant chimeer eiwit, bestaande uit vijf antigenefragmenten van vier verschillende Leishmania infantum (zymodeme Mon-1) eiwitten
ATE326981T1 (de) Isolierte peptide die aminosäuresequenzen von ny- eso-1 entsprechen und an mhc-klasse i und mhc klasse ii moleküle binden, und deren verwendungen
ATE215830T1 (de) Verfahren zur detektion und behandlung von individuen mit abnormal hla-a2/tyrosinase- peptidantigenen exprimierenden zellen
ATE239502T1 (de) Impfung mit peptiden von mhc klasse ii molekülen zur behandlung von autoimmunkrankheiten
ATE202114T1 (de) Verwendung von peptiden welche eine immunantwort bewirken zur herstellung von medikamenten zur induzierung der immunsuppression.
ATE293994T1 (de) Multivalente rekombinante antikörper zur behandlung von hrv infektionen
ATE234358T1 (de) Peptide des pferdearteritisvirus, antikörper und ihre verwendung in einem diagnostischen test

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties